Skip to main content
Pangea Wellness Inc. logo

Pangea Wellness Inc. — Investor Relations & Filings

Ticker · PNGA ISIN · CA6979501039 CSE Manufacturing
Filings indexed 244 across all filing types
Latest filing 2026-04-07 Regulatory Filings
Country CA Canada
Listing CSE PNGA

About Pangea Wellness Inc.

https://pangea-wellness.com/

Pangea Wellness Inc. is a North American manufacturer and distributor specializing in clean-label foods and innovative wellness products. The company focuses on creating high-quality, plant-based products that emphasize nutrition, sustainability, and convenience. Pangea Wellness operates through multiple brands, including its subsidiary, Amino Innovations, which develops science-backed wellness solutions. Amino Innovations specializes in advanced peptide therapies (such as BPC and Epitalon) delivered via accessible oral and topical systems, aiming to provide effective alternatives to traditional methods. Pangea Wellness products are distributed across North America, available online and in over 500 premium retail locations.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Regulatory Filings Classification · 85% confidence The document is a corporate press release announcing the launch of a new company website and commentary on U.S. peptide policy. It is not a financial report (10-K, IR, ER), not a management presentation (IP), nor a shareholder vote or dividend notice, nor any regulated form. It does not present detailed financial data, governance policies, or executive changes. It is a general announcement that does not fit any specialized category, so it defaults to the fallback “Regulatory Filings” category (RNS).
2026-04-07 English
52-109FV2 - Certification of interim filings - CFO (E).pdf
Regulatory Filings Classification · 85% confidence The document is a Certificate of Interim Filings (Form 52-109FV2) under Canadian securities rules, signed by the CFO, and does not contain the interim financial statements or MD&A itself but is a standalone regulatory certification. It is not the interim report (IR) nor merely a notice of report publication (RPA), but rather a specific statutory filing form, best fitting the general Regulatory Filings category (RNS).
2026-04-02 English
52-109FV2 - Certification of interim filings - CEO (E).pdf
Regulatory Filings Classification · 90% confidence The document is a Form 52-109FV2 certification of interim filings under Canadian securities rules, signed by the CEO. It does not contain the interim financial report or MD&A itself, nor does it report financials or management discussion. Instead, it is a regulatory certification filing. There is no specific category for certification forms in the taxonomy, so this falls under the general “Regulatory Filings” (RNS) fallback.
2026-04-02 English
Interim MD&A - English.pdf
Management Reports Classification · 92% confidence The document is titled “Management’s Discussion and Analysis (MD&A)” and provides a detailed explanation of the company’s financial performance, business trends, and outlook for the interim period ended January 31, 2026. It references IFRS accounting standards, National Instrument 51-102F1 (Canadian MD&A regulation), and includes forward‐looking statements and operational highlights. This matches the definition of a Management Report (MDA) rather than an earnings release, interim financial statements, or investor presentation.
2026-04-02 English
Interim financial statements/report – English.pdf
Interim / Quarterly Report Classification · 100% confidence The document is titled 'CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS' for the three-month period ended January 31, 2026. It contains comprehensive financial statements (Statement of Financial Position, Statement of Loss and Comprehensive Loss, Statement of Changes in Shareholders' Equity, and Statement of Cash Flows) along with detailed notes to the financial statements. This fits the definition of an Interim/Quarterly Report (IR) as it provides substantive financial data and analysis for a period shorter than a full fiscal year. Q1 2026
2026-04-02 English
Notice.pdf
Regulatory Filings
2026-03-18 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.